For more than a century, Eli Lilly and Company has united caring with discovery
to make life better. At Eli Lilly and Company, we continuously focus on new and
innovative ways to fulfill our extraordinary purpose of making medicines that
help people live longer, healthier, more active lives.
* Are you looking to join a dynamic company striving to improve the
lives of people across the world?
* Do you have the passion, curiosity, creativity to dream and the
persistence to get results?
* Do you have the scientific and technical expertise to influence and
apply model-based drug discovery and development?
* Can you communicate effectively with confidence?
If you answered yes then we are looking for you. Eli Lilly and Company is
looking for creative, motivated and enthusiastic scientists to join Global
Pharmacokinetics/Pharmacodynamics and Pharmacometrics department.
The scientists in the department of PK/PD & Pharmacometrics are the team
leaders in research and development throughout the value chain from preclinical
lead molecule identification to clinical post-drug approval with the goal of
identifying and developing the right drug with the right dose for the right
patient and living the model-informed paradigm of drug research and
development. Our organization is looking for a dynamic scientist who is able to:
* Develop and implement PK/PD approaches and Pharmacometrics strategies
to address key questions and influence portfolio decisions, including, but not
limited to the application of drug-disease models, literature models,
quantitative risk/benefit decision tools, quantitative systems pharmacology
models and trial-design optimization analytics.
* Provide scientific leadership in project teams to support the
selection of the right target, molecule, dose, patient population and
development strategies.
* Expect and understand the issues affecting the drug
discovery/development and help derive effective solutions. Support
decision-making through partnership and collaboration with cross-functional
teams and leadership.
* Lead and support the preparation and delivery of overall program
plan, individual study protocols, analysis plans, data interpretation and study
reports.
* Assist in the preparation of relevant sections of INDs, IBs, CTDs and
other regulatory documents for development and registration of new drugs and
line extensions; interact with FDA, EMA, PMDA and other regulatory agencies.
* Provide coaching and mentoring to fellow scientists within the group
and in other disciplines as well as interact, teach and collaborate with
academia.
* Represent the group to increase visibility externally, through key
publications, active leadership in key scientific organizations, industry trade
groups or consortia.
In summary, in this exciting role you will have opportunities to contribute in
developing strategies, setting direction for the organization, and drive
successful implementation of the strategies to produce results.
Basic Qualifications:
- PhD and/or MD in relevant scientific field such as
biological/pharmaceutical sciences, engineering or related field.
- Excellent understanding of clinical pharmacology (PK, PD and
pharmacometrics) principles.
- While experience from industry, regulatory, consulting or academia
with exposure to industry is preferred, we are also looking for enthusiastic
new graduates.
Lilly is an EEO/Affirmative Action Employer and does not discriminate on the
basis of age, race, color, religion, gender, sexual orientation, gender
identity, gender expression, national origin, protected veteran status,
disability or any other legally protected status.
If you're interested, please apply at
https://careers.lilly.com/job/indianapolis/research-scientist-project-leader-in-pk-pd-and-pharmacometrics/410/8192864
CONFIDENTIALITY NOTICE: This e-mail message (including all attachments) is for
the sole use of the intended recipient(s) and may contain confidential and
privileged information. Any unauthorized review, use, disclosure, copying or
distribution is strictly prohibited. If you are not the intended recipient,
please contact the sender by reply e-mail and destroy all copies of the
original message.